Aandelen in “Gezondheidstechnologie”

Aandeel Datum Koers Evolutie
vlag Y-Mabs Therapeutics Inc 21:39 11,770 USD
+1,47% 		+1,47%
vlag Yourgene Health Plc 7/09 0,515 GBX
0,00% 		0,00%

Nieuws over “Gezondheidstechnologie”

20:15 · Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM · Persbericht

20:15 · Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM · Persbericht

16:54 · MiniMed™ 780G system recognized among Fast Company's 2024 World Changing Ideas · Persbericht

14:30 · Zimmer Biomet Announces 2024 Investor Day · Persbericht

14:30 · Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine · Persbericht

13:30 · Soligenix Encourages Stockholders to Vote Prior to Annual Meeting · Persbericht

13:00 · Compugen Reports First Quarter 2024 Results · Persbericht

13:00 · PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation · Persbericht

12:00 · BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn · Persbericht

11:45 · QuidelOrtho Corporation f/k/a Quidel Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your Rights - QDEL · Persbericht

08:50 · Goud en zilver noteren explosief hoger en laag volume op Europese beurzen · LYNX

Deze week openen verschillende Amerikaanse bedrijven uit de detailhandel en retailsector hun boeken. Dit biedt inzicht in mogelijke trends en patronen binnen het consumentenuitgavegedrag, met focus op grote namen zoals Lowe’s...

08:00 · Pharming Group to participate in May investor conference · Persbericht

19/05 · NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD · Persbericht

18/05 · MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints · Persbericht

17/05 · BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification · Persbericht

17/05 · Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment · Persbericht

17/05 · DBV Technologies Announces Plan to Implement ADS Ratio Change · Persbericht

17/05 · TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

17/05 · Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™ · Persbericht

17/05 · QDEL Investors Have Opportunity to Lead QuidelOrtho Corporation Securities Fraud Lawsuit · Persbericht

17/05 · Novo Nordisk A/S - share repurchase programme · Persbericht

Mijn selecties